Sarah Hein | BiotechTV

top of page

Nov 7, 2024

Texas Life Science Forum: March Biosciences closed a $28.4M series A round last month to advance its CD5 targeting CAR-T

CEO Sarah Hein describes the rationale for CD5, and share her experience of what it was like making the raise come together. Brought to...

An entrepreneur describes launching a cell therapy startup in Houston

Sep 23, 2023

Bright Minds

An entrepreneur describes launching a cell therapy startup in Houston

March Biosciences’ CEO Sarah Hein on the infrastructure available in Houston for biotech startups, and the science behind her CD5 CAR-T.

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

At Savills, the Life Sciences Team specializes in helping biotech companies unlock their full potential by aligning real estate strategies with their scientific and business goals. As a leading global commercial real estate advisory firm, we focus exclusively on occupier services and tenant representation, acting as a trusted partner to some of the most innovative companies in the industry.

Visit Savills' Life Sciences Overview

bottom of page

Texas Life Science Forum: March Biosciences closed a $28.4M series A round last month to advance its CD5 targeting CAR-T

An entrepreneur describes launching a cell therapy startup in Houston

Follow BiotechTV

Sponsors

Sponsor Spotlight